Panagora Asset Management Inc I Mab Transaction History

Panagora Asset Management Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$8.27 - $18.43 $47,147 - $105,069	-5,701 Reduced 21.57%	20,724 $234,000
Q1 2022 May 12, 2022	BUY	$12.54 - $46.93 $160,662 - $601,267	12,812 Added 94.12%	26,425 $429,000
Q4 2021 Feb 10, 2022	BUY	$45.28 - $74.5 $180,259 - $296,584	3,981 Added 41.33%	13,613 $645,000
Q3 2021 Nov 10, 2021	BUY	$57.18 - $84.43 $247,989 - $366,172	4,337 Added 81.91%	9,632 $698,000
Q2 2021 Aug 11, 2021	BUY	$47.86 - $83.95 $253,418 - $444,515	5,295 New	5,295 $445,000

15.5M

56.4K

5.8K

Ticker IMAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,098,800
Market Cap $77.3M
Description
I-Mab, a clinical stage biopharmaceutical company, discovers, develops, and commercializes biologics to treat cancer and autoimmune disorders. It is developing Felzartamab, a CD38 antibody that is in Phase 1b/2a for patients with membranous nephropathy; Eftansomatropin alfa, a long-acting human growth hormone, which has completed Phase 3 clinica...

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Panagora Asset Management Inc with notifications on news.